Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report)’s stock price gapped up before the market opened on Wednesday. The stock had previously closed at $8.87, but opened at $9.13. Haleon shares last traded at $9.0650, with a volume of 2,350,681 shares traded.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on HLN shares. Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. Morgan Stanley restated an “overweight” rating on shares of Haleon in a research note on Thursday, August 6th. Rothschild & Co Redburn cut Haleon from a “strong-buy” rating to a “hold” rating in a report on Tuesday, June 16th. Zacks Research upgraded Haleon from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 19th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Haleon in a report on Wednesday, September 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.
Check Out Our Latest Research Report on HLN
Haleon Stock Up 2.6%
Haleon Cuts Dividend
The company also recently disclosed a dividend, which was paid on Thursday, September 17th. Shareholders of record on Friday, August 14th were given a dividend of $0.0642 per share. This is a decrease from Haleon’s previous dividend of $0.1307. This represents a yield of 132.0%. The ex-dividend date was Friday, August 14th. Haleon’s dividend payout ratio (DPR) is presently 30.77%.
Institutional Investors Weigh In On Haleon
A number of large investors have recently modified their holdings of the business. Western Wealth Management LLC acquired a new position in shares of Haleon during the 1st quarter worth $29,000. Annis Gardner Whiting Capital Advisors LLC boosted its stake in Haleon by 402.0% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after buying an additional 2,404 shares in the last quarter. Parkside Financial Bank & Trust boosted its stake in Haleon by 20.4% in the second quarter. Parkside Financial Bank & Trust now owns 6,233 shares of the company’s stock valued at $58,000 after buying an additional 1,055 shares in the last quarter. Fiduciary Financial Group LLC bought a new position in Haleon in the second quarter valued at about $97,000. Finally, Gryphon Financial Partners LLC bought a new position in Haleon in the first quarter valued at about $101,000. Institutional investors and hedge funds own 6.67% of the company’s stock.
Haleon Company Profile
Haleon plc (NYSE: HLN) is a global consumer healthcare company headquartered in Weybridge, England. The company develops, manufactures and markets over-the-counter medicines, oral healthcare products, nutritional supplements and other consumer health products sold through pharmacies, retailers and e-commerce channels.
Its portfolio includes well-known brands such as Sensodyne, Polident and parodontax in oral healthcare; Advil, Panadol, Voltaren and Theraflu in pain relief and respiratory care; and Centrum and Emergen-C in vitamins, minerals and supplements.
Featured Articles
- Five stocks we like better than Haleon
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
